11C-Acetate PET Imaging in Hepatocellular Carcinoma and Other Liver Masses

It is well known that (18)F-FDG PET has a high average false-negative rate of 40%-50% in the detection of hepatocellular carcinoma (HCC). This is not an acceptable accuracy, particularly in countries where this tumor is prevalent. In this study, we evaluated prospectively the characteristics of (11)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of nuclear medicine (1978) 2003-02, Vol.44 (2), p.213-221
Hauptverfasser:	Ho, Chi-Lai, Yu, Simon C.H, Yeung, David W.C
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetates - pharmacokinetics Adult Aged Aged, 80 and over Breast Neoplasms - pathology Carbon Radioisotopes Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - diagnostic imaging Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - secondary Cholangiocarcinoma - diagnostic imaging Cholangiocarcinoma - metabolism Cholangiocarcinoma - pathology Cholangiocarcinoma - secondary Colonic Neoplasms - pathology False Negative Reactions Female Fluorodeoxyglucose F18 - pharmacokinetics Humans Liver Neoplasms - diagnosis Liver Neoplasms - diagnostic imaging Liver Neoplasms - metabolism Liver Neoplasms - secondary Lung Neoplasms - pathology Male Middle Aged Prospective Studies Radionuclide Imaging Radiopharmaceuticals - pharmacokinetics Reproducibility of Results Sensitivity and Specificity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!